BridgeMD
New treatment option for Paroxysmal Atrial Fibrillation
Official title Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation
ClinicalTrials.gov ID: NCT05996159
What this study is testing
- What it's testing
- This study aims to investigate the effect of reducing ablation time for a hybrid approach of vHPSD and AI-guided ablation using the QDOT Micro catheter in PVI among patients with PAF.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Patients undergoing PVI for PAF
You likely can't join if
- Aged less than 19 years
- Patients with persistent AF
- Patients with previous ablation or surgery for AF
- Patients with intracardiac thrombus or thromboembolic events within the previous 90 days
- Patients with cardiac surgery or acute coronary syndrome within the previous 90 days
- Patients with contraindication(s) for using oral anticoagulants
See the full eligibility criteria
- Patients undergoing PVI for PAF
- Aged less than 19 years
- Patients with persistent AF
- Patients with previous ablation or surgery for AF
- Patients with intracardiac thrombus or thromboembolic events within the previous 90 days
- Patients with cardiac surgery or acute coronary syndrome within the previous 90 days
- Patients with contraindication(s) for using oral anticoagulants
- Patients with LA anteroposterior diameter of more than 55 mm
- Patients with left ventricular ejection fraction less than 35%
- Pregnants or those who plan to become pregnant during the study
- Life expectancy less than a year
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.